The Value Creation Plan presented at Capital Markets Day, CMD, is based on 3 pillars: Commercial Growth: Grifols (GRFS) plans to capitalize on ...

In response, Grifols, a global leader in plasma science and the production of plasma-derived medicines, has embarked on a groundbreaking program in partnership with The Michael J. Fox Foundation ...

More than two dozen people rallied on Monday against a new for-profit clinic in Whitby that pays people for plasma donations. Demonstrators marched outside the office of the Grifols Plasma Donation ...

leading to new diagnostic tools and disease-modifying therapiesPart of broad Grifols program to find disease-revealing clues in more than 100 million proprietary plasma samples connected to real ...

"Grifols developed its new fibrinogen to be more convenient, faster to prepare and storable at room temperature, an advantage over alternatives such as cryoprecipitate or fresh frozen plasma when ...

After hours: March 6 at 6:13:25 PM EST Loading Chart for GRFS ...

At the same time, Grifols has formed a strategic alliance with Haier in the market for plasma products, particularly albumin, and diagnostics. It has been involved in a series of acquisitions in ...

If you’ve been thinking about selling plasma as a way to make some extra cash, you’re not alone. According to a Western ...

The plasma-derived therapies market continues to show strong demand. Grifols demonstrated solid performance in 2024, with significant revenue growth and operational improvements. The company's ...